Print Join the Discussion View in the ACM Digital Library The mathematical reasoning performed by LLMs is fundamentally different from the rule-based symbolic methods in traditional formal reasoning.

Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

Theorem raises $6 million to use AI-powered formal verification to mathematically prove AI-generated code is safe before it's deployed in critical systems.

Obvious Ventures, the firm co-founded by Twitter’s Evan Williams, has raised a fifth fund, and this one, just like its predecessors, comes with a “fun” number: $360,360,360.

PHI-Enhanced Recursive Language Model (RLM) Framework A groundbreaking implementation of Recursive Language Models enhanced with φ-Separation Mathematics, leveraging the profound connections between ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...